Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Rite Aid Corporation

RADNYSE
Healthcare
Medical - Pharmaceuticals
$0.65
$-0.13(-16.81%)
U.S. Market opens in 17h 21m

Rite Aid Corporation Fundamental Analysis

Rite Aid Corporation (RAD) shows weak financial fundamentals with a PE ratio of -0.05, profit margin of -3.11%, and ROE of 2.76%. The company generates $25.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position443.32%
PEG Ratio-0.00

Areas of Concern

ROE2.76%
Operating Margin-0.41%
We analyze RAD's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 157.7/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.

Fundamental Health Score

A
157.7/100

We analyze RAD's fundamental strength across five key dimensions:

Efficiency Score

Weak

RAD struggles to generate sufficient returns from assets.

ROA > 10%
-9.96%

Valuation Score

Excellent

RAD trades at attractive valuation levels.

PE < 25
-0.05
PEG Ratio < 2
-0.00

Growth Score

Weak

RAD faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

RAD maintains a strong and stable balance sheet.

Debt/Equity < 1
-9.07
Current Ratio > 1
1.21

Profitability Score

Weak

RAD struggles to sustain strong margins.

ROE > 15%
276.35%
Net Margin ≥ 15%
-3.11%
Positive Free Cash Flow
No

Key Financial Metrics

Is RAD Expensive or Cheap?

P/E Ratio

RAD trades at -0.05 times earnings. This suggests potential undervaluation.

-0.05

PEG Ratio

When adjusting for growth, RAD's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Rite Aid Corporation at -0.06 times its book value. This may indicate undervaluation.

-0.06

EV/EBITDA

Enterprise value stands at 181.34 times EBITDA. This signals the market has high growth expectations.

181.34

How Well Does RAD Make Money?

Net Profit Margin

For every $100 in sales, Rite Aid Corporation keeps $-3.11 as profit after all expenses.

-3.11%

Operating Margin

Core operations generate -0.41 in profit for every $100 in revenue, before interest and taxes.

-0.41%

ROE

Management delivers $2.76 in profit for every $100 of shareholder equity.

2.76%

ROA

Rite Aid Corporation generates $-9.96 in profit for every $100 in assets, demonstrating efficient asset deployment.

-9.96%

Following the Money - Real Cash Generation

Operating Cash Flow

Rite Aid Corporation generates limited operating cash flow of $-54.37M, signaling weaker underlying cash strength.

$-54.37M

Free Cash Flow

Rite Aid Corporation generates weak or negative free cash flow of $-311.19M, restricting financial flexibility.

$-311.19M

FCF Per Share

Each share generates $-5.49 in free cash annually.

$-5.49

FCF Yield

RAD converts -8.17% of its market value into free cash.

-8.17%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.05

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.06

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.002

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-9.07

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.21

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

2.76

vs 25 benchmark

ROA

Return on assets percentage

-0.10

vs 25 benchmark

ROCE

Return on capital employed

-0.02

vs 25 benchmark

How RAD Stacks Against Its Sector Peers

MetricRAD ValueSector AveragePerformance
P/E Ratio-0.0529.43 Better (Cheaper)
ROE276.35%800.00% Weak
Net Margin-3.11%-20145.00% (disorted) Weak
Debt/Equity-9.070.30 Strong (Low Leverage)
Current Ratio1.214.64 Neutral
ROA-9.96%-17936.00% (disorted) Weak

RAD outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Rite Aid Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ